Ghost Tree Capital as of March 31, 2014
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 65 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Index option | 10.4 | $18M | 150k | 116.34 | |
| Merck & Co Inc New option | 8.4 | $14M | 250k | 56.77 | |
| Teva Pharmaceutical Inds Ltd option | 4.7 | $7.9M | 150k | 52.84 | |
| Gilead Sciences Inc option | 4.2 | $7.1M | 100k | 70.86 | |
| Bristol-myers Squibb | 3.1 | $5.2M | 100k | 51.95 | |
| Mylan Inc Cmn Stock cmn | 2.9 | $4.9M | 100k | 48.83 | |
| AEGERION Pharmaceuticals Inc cmn | 2.7 | $4.6M | 100k | 46.18 | |
| Vertex Pharmaceuticals Inc option | 2.7 | $4.6M | 65k | 70.72 | |
| Prothena (PRTA) | 2.5 | $4.2M | 110k | 38.31 | |
| Bristol Myers Squibb (BMY) | 2.5 | $4.2M | 80k | 51.95 | |
| Flamel Technologies | 2.4 | $4.0M | 300k | 13.40 | |
| Accuray Incorporated (ARAY) | 2.3 | $3.8M | 400k | 9.60 | |
| Insmed | 2.3 | $3.8M | 200k | 19.04 | |
| AMAG Pharmaceuticals | 2.2 | $3.7M | 192k | 19.35 | |
| Chelsea Therapeutics International | 2.0 | $3.3M | 600k | 5.52 | |
| Unilife US | 1.9 | $3.3M | 800k | 4.07 | |
| Community Health Systems (CYH) | 1.9 | $3.1M | 80k | 39.18 | |
| Arrowhead Research | 1.8 | $3.0M | 185k | 16.42 | |
| GROUP Affymetrix Inc cnv | 1.8 | $3.0M | 425k | 7.13 | |
| Tornier Nv | 1.6 | $2.8M | 130k | 21.22 | |
| Intercept Pharmaceuticals In | 1.6 | $2.6M | 8.0k | 329.75 | |
| Insmed (INSM) | 1.5 | $2.6M | 135k | 19.04 | |
| Tandem Diabetes Care | 1.5 | $2.5M | 115k | 22.09 | |
| Merit Medical Systems (MMSI) | 1.5 | $2.5M | 175k | 14.30 | |
| Ocera Therapeutics | 1.5 | $2.5M | 235k | 10.55 | |
| Furiex Pharmaceuticals | 1.4 | $2.4M | 28k | 87.02 | |
| Edwards Lifesciences (EW) | 1.3 | $2.2M | 30k | 74.17 | |
| Intuitive Surgical (ISRG) | 1.3 | $2.2M | 5.0k | 438.00 | |
| Bruker Corporation (BRKR) | 1.2 | $2.1M | 90k | 22.79 | |
| Biogen Idec (BIIB) | 1.2 | $2.0M | 6.5k | 305.83 | |
| D Horizon Pharma | 1.2 | $2.0M | 130k | 15.12 | |
| Align Technology (ALGN) | 1.1 | $1.8M | 35k | 51.80 | |
| Dyax | 1.1 | $1.8M | 200k | 8.98 | |
| Conatus Pharmaceuticals | 1.1 | $1.8M | 220k | 8.14 | |
| Chelsea Therapeutics Interna cmn | 1.0 | $1.7M | 300k | 5.52 | |
| AtriCure (ATRC) | 0.9 | $1.6M | 85k | 18.81 | |
| Sangamo Biosciences (SGMO) | 0.9 | $1.6M | 87k | 18.08 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $1.5M | 75k | 20.65 | |
| Spectranetics Corporation | 0.9 | $1.5M | 50k | 30.32 | |
| Illumina (ILMN) | 0.9 | $1.5M | 10k | 148.70 | |
| Gw Pharmaceuticals Plc ads | 0.9 | $1.5M | 25k | 59.36 | |
| DepoMed | 0.9 | $1.5M | 100k | 14.50 | |
| Lannett Company | 0.8 | $1.4M | 40k | 35.72 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $1.4M | 35k | 40.00 | |
| Therapeuticsmd | 0.8 | $1.3M | 200k | 6.31 | |
| Puma Biotechnology (PBYI) | 0.7 | $1.2M | 11k | 104.15 | |
| NuVasive | 0.7 | $1.2M | 30k | 38.40 | |
| Epizyme | 0.6 | $1.0M | 45k | 22.78 | |
| Kythera Biopharmaceuticals I | 0.6 | $994k | 25k | 39.76 | |
| Antares Pharma | 0.5 | $875k | 250k | 3.50 | |
| Tearlab Corp | 0.5 | $845k | 125k | 6.76 | |
| NxStage Medical | 0.5 | $796k | 63k | 12.74 | |
| EnteroMedics | 0.4 | $728k | 400k | 1.82 | |
| Biolase Technology | 0.4 | $723k | 300k | 2.41 | |
| Flexion Therapeutics | 0.4 | $658k | 40k | 16.45 | |
| Revance Therapeutics (RVNC) | 0.4 | $630k | 20k | 31.50 | |
| Amarin Corporation (AMRN) | 0.3 | $543k | 300k | 1.81 | |
| Novavax | 0.3 | $453k | 100k | 4.53 | |
| Dynavax Technologies Corporation | 0.3 | $448k | 247k | 1.81 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $452k | 200k | 2.26 | |
| Anacor Pharmaceuticals In | 0.2 | $400k | 20k | 20.00 | |
| Sorrento Therapeutics (SRNEQ) | 0.2 | $385k | 30k | 12.83 | |
| DURECT Corporation | 0.2 | $333k | 250k | 1.33 | |
| Ignyta | 0.1 | $195k | 24k | 8.30 | |
| Wright Med Group Inc right 03/01/2019 | 0.0 | $46k | 55k | 0.83 |
